Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 335.00
Bid: 322.00
Ask: 398.00
Change: 0.00 (0.00%)
Spread: 76.00 (23.602%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 335.00
ROR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

24 Sep 2015 10:38

RNS Number : 0852A
Rotork PLC
24 September 2015
 



 

Annex DTR3

 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

 

 

All relevant boxes should be completed in block capital letters.

 

1.

Name of the issuer

 

 

ROTORK PLC

2.

State whether the notification relates to (i) a

transaction notified in accordance with DTR 3.1.2 R,

(ii) a disclosure made in accordance

LR 9.8.6R(1) or

(iii) a disclosure made in accordance with section 793 of the Companies Act (2006).

DTR 3.1.2 R

3.

Name of person discharging managerial

responsibilities/director

 

JONATHAN MARK DAVIS

4.

State whether notification relates to a person

connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

CAROL ELIZABETH DAVIS

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a nonbeneficial

interest 1

 

PERSON IN 4

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

 

ORDINARY 5P SHARES

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

 

HARGREAVES LANSDOWN

 

8.

State the nature of the transaction

 

 

SHARE PURCHASE

9.

Number of shares, debentures or financial

instruments relating to shares acquired

 

6,000 SHARES

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

 

LESS THAN 0.01% OF ISSUED CLASS

11.

Number of shares, debentures or financial

instruments relating to shares disposed

 

N/A

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

 

N/A

13.

Price per share or value of transaction

 

£1.694 PER SHARE

14.

Date and place of transaction

 

LONDON, ENGLAND 24/09/2015

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

203,624 SHARES (LESS THAN 0.1% OF ISSUED CAPITAL)

16.

Date issuer informed of transaction

 

24/09/2015

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

 

17.

Date of grant

 

N/A

18.

Period during which or date on which exercisable

N/A

 

19.

Total amount paid (if any) for grant of the option

N/A

20.

Description of shares or debentures involved (class and number)

 

N/A

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

N/A

22.

Total number of shares or debentures over which options held following notification

 

N/A

23.

Any additional information

N/A

24.

Name of contact and telephone number for queries

STEPHEN RHYS JONES, COMPANY SECRETARY, 01225 733331

 

 

 

Name of authorised official of issuer responsible for making notification

MIRIAM PARKMAN, ASSISTANT COMPANY SECRETARY

 

Date of notification

24/09/2015

 

 

Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.

 

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGCGDCRDDBGUS
Date   Source Headline
29th Jun 202310:45 amRNSDirectorate Change
19th Jun 202311:00 amRNSDirector Declaration
14th Jun 20233:30 pmRNSHolding(s) in Company
13th Jun 20231:00 pmRNSDirector/PDMR Shareholding
8th Jun 202312:26 pmRNSTotal Voting Rights
15th May 20234:15 pmRNSDirector/PDMR Shareholding
2nd May 20233:15 pmRNSTotal Voting Rights
28th Apr 20233:45 pmRNSDirector/PDMR Shareholding
28th Apr 20233:22 pmRNSResult of AGM
28th Apr 20237:00 amRNSTrading Update
12th Apr 20233:00 pmRNSDirector/PDMR Shareholding
6th Apr 20234:45 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:00 pmRNSTotal Voting Rights
29th Mar 20232:30 pmRNSDirector/PDMR Shareholding
27th Mar 20236:21 pmRNSDirector/PDMR Shareholding
24th Mar 20233:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20234:46 pmRNS2022 Annual Report and Notice of 2023 AGM
15th Mar 20234:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
13th Mar 20233:30 pmRNSDirector/PDMR Shareholding
7th Mar 202311:00 amRNSDirector/PDMR Shareholding
1st Mar 20233:00 pmRNSTotal Voting Rights
28th Feb 20237:00 amRNS2022 Preliminary Results
13th Feb 20233:30 pmRNSDirector/PDMR Shareholding
1st Feb 20234:00 pmRNSTotal Voting Rights
11th Jan 20234:00 pmRNSDirector/PDMR Shareholding
3rd Jan 202311:30 amRNSTotal Voting Rights
13th Dec 20224:00 pmRNSDirector/PDMR Shareholding
1st Dec 20222:00 pmRNSTotal Voting Rights
1st Dec 20227:00 amRNSAppointment of Chair Designate
25th Nov 20223:00 pmRNSHolding(s) in Company
23rd Nov 20227:00 amRNSTrading Update
17th Nov 20223:30 pmRNSHolding(s) in Company
16th Nov 20223:30 pmRNSHolding(s) in Company
11th Nov 20223:00 pmRNSDirector/PDMR Shareholding
4th Nov 20225:15 pmRNSHolding(s) in Company
3rd Nov 202211:00 amRNSHolding(s) in Company
2nd Nov 20227:00 amRNSCapital Markets Event
1st Nov 20223:30 pmRNSHolding(s) in Company
1st Nov 202211:00 amRNSTotal Voting Rights
31st Oct 20223:30 pmRNSHolding(s) in Company
28th Oct 20223:00 pmRNSHolding(s) in Company
25th Oct 20229:00 amRNSNear-term emissions targets approved by SBTi
17th Oct 20223:00 pmRNSHolding(s) in Company
13th Oct 20224:30 pmRNSHolding(s) in Company
13th Oct 20223:00 pmRNSHolding(s) in Company
12th Oct 20224:00 pmRNSDirector/PDMR Shareholding
12th Oct 20223:00 pmRNSHolding(s) in Company
11th Oct 20224:00 pmRNSDirector/PDMR Shareholding
5th Oct 20229:30 amRNS2022 AGM Voting Outcome Update Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.